Maximum Strength Coenzyme Q10 With Exclusive VESIsorb® Technology For Enhanced Absorption.
- Provide enhanced absorption technology versus oil-based CoQ10 via an exclusive VESIsorb® delivery system.
- Support cellular energy production and heart health.
Adults: Take 1 capsule daily.
Store below 30° C
Each capsule contains: |
|
Ubidecarenone (Coenzyme Q10) |
150 mg |
Contains Sulfites. Free from corn, dairy protein, lactose, eggs, gluten, wheat, nuts, yeast, soy protein and starches. Free from artificial sweeteners and flavours.
Excipients: Colour, D-alpha-tocopheryl acetate, Gelatin, Glycerol, Linoleic acid, Medium chain triglycerides, Olive Oil, Orange Oil, PEG-35 castor oil, PEG-40 hydrogenated castor oil, Polysorbate 80, Purified water.
Do not take while on warfarin therapy without medical advice.
Product presentation must not imply or refer to serious cardiovascular conditions.
Product presentation must not imply or refer to chronic fatigue syndrome.
Product presentation must not imply or refer to circulatory disorders/diseases/conditions e.g. thrombosis.
Not all cautions and contraindications are listed. For full details, references or more information contact Metagenics in Australia on 1800 777 648 or in New Zealand on 0508 227 744.
Maximum Strength Coenzyme Q10 With Exclusive VESIsorb® Technology For Enhanced Absorption.
- Provide enhanced absorption technology versus oil-based CoQ10 via an exclusive VESIsorb® delivery system.
- Support cellular energy production and heart health.
Adults: Take 1 capsule daily.
Store below 30° C
Each capsule contains: |
|
Ubidecarenone (Coenzyme Q10) |
150 mg |
Contains Sulfites. Free from corn, dairy protein, lactose, eggs, gluten, wheat, nuts, yeast, soy protein and starches. Free from artificial sweeteners and flavours.
Excipients: Colour, D-alpha-tocopheryl acetate, Gelatin, Glycerol, Linoleic acid, Medium chain triglycerides, Olive Oil, Orange Oil, PEG-35 castor oil, PEG-40 hydrogenated castor oil, Polysorbate 80, Purified water.
Do not take while on warfarin therapy without medical advice.
Product presentation must not imply or refer to serious cardiovascular conditions.
Product presentation must not imply or refer to chronic fatigue syndrome.
Product presentation must not imply or refer to circulatory disorders/diseases/conditions e.g. thrombosis.
Not all cautions and contraindications are listed. For full details, references or more information contact Metagenics in Australia on 1800 777 648 or in New Zealand on 0508 227 744.